Mid Year Update

The first half of 2019 continues to show continuity with prior periods. Debt and equity availability remain strong while deal flow, although somewhat diminished due to consolidation, is still good. Therefore multiples are similar or stronger (before adjustment for size). Although some warning signs are on the horizon, these have yet to make themselves fully felt in MedTech markets. Click here to read the full report.